Medpace Holdings, Inc.

XNASHealth care

Last traded price · USD

$657.15

+0.06%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:59 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $656.77
Volume: 1
Day's high: —
Day's low: —

In brief

Medpace Holdings, Inc. is a health care company listed on Nasdaq, valued at about $18.38B.
Its shares closed at $656.77 on 4 Nov 2026, up 10.5% over the past year.
From India you can buy MEDP in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Medpace Holdings, Inc. (MEDP) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole MEDP share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade MEDP options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

5.4% below its 52-week high
Closed at $656.77 on 4 Nov 2026: 5.4% below the 52-week high of $693.97 (28 Oct 2026) and 76.1% above the low of $373.00 (23 Apr 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
6.6 days to cover short interest
1.6M shares were sold short at the 15 Oct 2026 settlement, 5.8% of the 28.0M shares outstanding; covering them would take 6.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +8.9% (SPY −1.6%, XLV +13.5%). 3 months: +11.7% (SPY −0.4%, XLV +15.5%). 1 year: +10.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MEDP, SPY and XLV · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $656.77 was 5.7% above its 50-day average ($621.39) and 23.9% above its 200-day average ($530.06). It has closed above the 200-day for 94 sessions, since 24 Jun 2026. The 50-day average crossed above the 200-day on 7 Aug 2026, 62 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+8.9%

6 months+53.9%

1 year+10.5%

5 years+188.8%

Newswire

About

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Website

Notable moves

April 23, 2026
−22.63%
July 22, 2025
+54.67%
October 25, 2022
+37.71%

Newswire

About

Website

Notable moves

April 23, 2026
−22.63%
July 22, 2025
+54.67%
October 25, 2022
+37.71%

Medpace Holdings, Inc.

XNASHealth care

Last traded price · USD

$657.15

+0.06%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:59 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $656.77
Volume: 1
Day's high: —
Day's low: —

In brief

Medpace Holdings, Inc. is a health care company listed on Nasdaq, valued at about $18.38B.
Its shares closed at $656.77 on 4 Nov 2026, up 10.5% over the past year.
From India you can buy MEDP in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Medpace Holdings, Inc. (MEDP) shares from India?

Do I need the price of a whole MEDP share to invest?

How much can I invest in US stocks in a year?

Can I trade MEDP options or futures?

Insights

Quotes run fifteen minutes behind.

5.4% below its 52-week high
Closed at $656.77 on 4 Nov 2026: 5.4% below the 52-week high of $693.97 (28 Oct 2026) and 76.1% above the low of $373.00 (23 Apr 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
6.6 days to cover short interest
1.6M shares were sold short at the 15 Oct 2026 settlement, 5.8% of the 28.0M shares outstanding; covering them would take 6.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +8.9% (SPY −1.6%, XLV +13.5%). 3 months: +11.7% (SPY −0.4%, XLV +15.5%). 1 year: +10.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MEDP, SPY and XLV · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $656.77 was 5.7% above its 50-day average ($621.39) and 23.9% above its 200-day average ($530.06). It has closed above the 200-day for 94 sessions, since 24 Jun 2026. The 50-day average crossed above the 200-day on 7 Aug 2026, 62 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+8.9%

6 months+53.9%

1 year+10.5%

5 years+188.8%

Newswire

About

Website

Notable moves

April 23, 2026
−22.63%
July 22, 2025
+54.67%
October 25, 2022
+37.71%

Newswire

About

Website

Notable moves

April 23, 2026
−22.63%
July 22, 2025
+54.67%
October 25, 2022
+37.71%

Medpace Holdings, Inc.

Medpace Holdings, Inc. in brief

5.4% below its 52-week high

6.6 days to cover short interest

Behind SPY and its sector fund XLV over 1 year

Above its 50- and 200-day averages

Medpace Holdings, Inc.

Medpace Holdings, Inc. in brief

5.4% below its 52-week high

6.6 days to cover short interest

Behind SPY and its sector fund XLV over 1 year

Above its 50- and 200-day averages